Sclerostin is an independent risk factor for all-cause mortality in kidney transplant recipients
Sclerostin is a hormone contributing to the bone-vascular wall cross talk and has been implicated in cardiovascular events and mortality in patients with chronic kidney disease (CKD). We analyzed the relationship between sclerostin and mortality in renal transplant recipients.
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
20 August 2020
|
| In: |
Clinical and experimental nephrology
Year: 2020, Jahrgang: 24, Heft: 12, Pages: 1177-1183 |
| ISSN: | 1437-7799 |
| DOI: | 10.1007/s10157-020-01956-y |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s10157-020-01956-y |
| Verfasserangaben: | Shufei Zeng, Torsten Slowinski, Wolfgang Pommer, Ahmed A. Hasan, Mohamed M. S. Gaballa, Yongping Lu, Bernhard K. Krämer, Berthold Hocher |
| Zusammenfassung: | Sclerostin is a hormone contributing to the bone-vascular wall cross talk and has been implicated in cardiovascular events and mortality in patients with chronic kidney disease (CKD). We analyzed the relationship between sclerostin and mortality in renal transplant recipients. |
|---|---|
| Beschreibung: | Gesehen am 12.08.2021 |
| Beschreibung: | Online Resource |
| ISSN: | 1437-7799 |
| DOI: | 10.1007/s10157-020-01956-y |